Switzerland· 67244001
Beovu
A brolucizumab product containing brolucizumabum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Brolucizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC S01LA06 (brolucizumab), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Brolucizumab · ATC S01LA06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- brolucizumabum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- S01LA06
- ATC class
- Brolucizumab
- Defined daily dose
- 0.0357 DE, IVT
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680672440019Fertspr 0.165 mlCHF 726.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brolucizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumBeovu 120 mg/mlNovartis Europharm
- CzechiaBEOVUNovartis Europharm Limited, Dublin
- IcelandBeovuNovartis Europharm Limited*
- SwedenBeovu 120 mg/ml Injektionsvätska, lösningNovartis Europharm Limited
- IrelandBeovu 120 mg/ml solution for injection in pre-filled syringeNovartis Europharm Limited
- PolandBeovuNovartis Europharm Limited
- NetherlandsBeovu 120 mg/ml, oplossing voor injectieNovartis Europharm Limited
- SpainBEOVU 120 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADANovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Beovu
- Liechtenstein · Beovu
- Norway · Beovu
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0afda4e3-710b-4989-a233-723bd1ba9059 GET /v1/drugs/0afda4e3-710b-4989-a233-723bd1ba9059?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "brolucizumabum 120 mg",
"valid_from": "2024-05-01",
"limitations": "[{\"description\":\"Für die Behandlung der exsudativen (feuchten) altersbezogenen Makuladegeneration (AMD).<br>\\nBEOVU darf ausschliesslich durch qualifizierte Ophthalmochirurgen der A-, B- und C-Zentren/Kliniken (gemäss der Liste der Weiterbildungszentren der FMH (http://www.siwf-register.ch) zu Lasten der obligatorischen Krankenpflegeversicherung (OKP) angewendet werden.<br>\\nAusnahmeregelung: Die Ausbildungskliniken A, B und C sind berechtigt, mit niedergelassenen Ophthalmochirurgen zu kooperieren, um eine patientennahe Versorgung zu gewährleisten.<br>\\nDie Kooperation geschieht auf einvernehmlicher Basis zwischen beiden Partnern und gemäss folgenden Bedingungen:<br>\\na) Die Ausbildungsklinik führt die Erstuntersuchung oder die Bestätigung der Diagnose durch. Dies muss für die Krankenkassen belegt werden.<br>\\nb) Bei Einigung auf die zugelassene Indikation darf auch der niedergelassene Arzt den Patienten weiterbehandeln.<br>\\nDie gleichzeitige Behandlung beider Augen eines Patienten bedarf der Bewilligung des Krankenversicherers nach vorgängiger Konsultation des Vertrauensarztes.<br>\\n<br>\\n\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2025-12-01\",\"validTo\":\"2027-04-30\"}]",
"galenic_form": "Inj Lös 6 mg/0.05ml Fertigspr",
"therapeutic_area": null,
"sl_inclusion_date": "2020-06-01",
"self_retention_pct": 10
}See everything about brolucizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.